Veradigm EBITDA 2010-2022 | MDRX
Veradigm ebitda from 2010 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Veradigm Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $89 |
| 2021 | $150 |
| 2020 | $95 |
| 2019 | $99 |
| 2018 | $29 |
| 2017 | $170 |
| 2016 | $204 |
| 2015 | $193 |
| 2014 | $135 |
| 2013 | $51 |
| 2012 | $164 |
| 2011 | $269 |
| 2010 | $56 |
| 2010 | $141 |
| 2009 | $69 |
| Veradigm Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2022-12-31 | $20 |
| 2022-09-30 | $39 |
| 2022-06-30 | $9 |
| 2022-03-31 | $21 |
| 2021-12-31 | $57 |
| 2021-09-30 | $35 |
| 2021-06-30 | $34 |
| 2021-03-31 | $24 |
| 2020-12-31 | $12 |
| 2020-09-30 | $36 |
| 2020-06-30 | $20 |
| 2020-03-31 | $28 |
| 2019-12-31 | $-81 |
| 2019-09-30 | $61 |
| 2019-06-30 | $61 |
| 2019-03-31 | $58 |
| 2018-12-31 | $-47 |
| 2018-09-30 | $48 |
| 2018-06-30 | $-13 |
| 2018-03-31 | $41 |
| 2017-12-31 | $-43 |
| 2017-09-30 | $79 |
| 2017-06-30 | $73 |
| 2017-03-31 | $61 |
| 2016-12-31 | $36 |
| 2016-09-30 | $61 |
| 2016-06-30 | $61 |
| 2016-03-31 | $46 |
| 2015-12-31 | $60 |
| 2015-09-30 | $50 |
| 2015-06-30 | $47 |
| 2015-03-31 | $36 |
| 2014-12-31 | $43 |
| 2014-09-30 | $24 |
| 2014-06-30 | $35 |
| 2014-03-31 | $33 |
| 2013-12-31 | $19 |
| 2013-09-30 | $3 |
| 2013-06-30 | $15 |
| 2013-03-31 | $14 |
| 2012-12-31 | $13 |
| 2012-09-30 | $47 |
| 2012-06-30 | $55 |
| 2012-03-31 | $48 |
| 2011-12-31 | $81 |
| 2011-09-30 | $68 |
| 2011-06-30 | $65 |
| 2011-03-31 | $55 |
| 2010-12-31 | $23 |
| 2010-09-30 | $16 |
| 2010-06-30 | $13 |
| 2010-05-31 | |
| 2010-03-31 | $59 |
| 2010-02-28 | $59 |
| 2009-12-31 | |
| 2009-11-30 | $45 |
| 2009-09-30 | $22 |
| 2009-08-31 | $22 |
| 2009-05-31 | |
| 2009-02-28 | $41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.503B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.457B | 60.38 |
| Hims & Hers Health (HIMS) | United States | $12.904B | 134.07 |
| Doximity (DOCS) | United States | $11.414B | 52.84 |
| Tempus AI (TEM) | United States | $11.164B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.284B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.801B | 59.38 |
| Hinge Health (HNGE) | United States | $3.571B | 0.00 |
| Privia Health (PRVA) | United States | $2.402B | 164.21 |
| 10x Genomics (TXG) | United States | $1.737B | 0.00 |
| Schrodinger (SDGR) | United States | $1.631B | 0.00 |
| Phreesia (PHR) | United States | $1.585B | 0.00 |
| Azenta (AZTA) | United States | $1.576B | 73.25 |
| Enovis (ENOV) | United States | $1.573B | 8.77 |
| Clover Health Investments (CLOV) | United States | $1.545B | 0.00 |
| Omnicell (OMCL) | United States | $1.324B | 23.36 |
| Evolent Health (EVH) | United States | $1.166B | 99.30 |
| Claritev (CTEV) | United States | $0.652B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.559B | 0.00 |
| Standard BioTools (LAB) | United States | $0.532B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.421B | 125.75 |
| TruBridge (TBRG) | United States | $0.353B | 783.33 |
| Outset Medical (OM) | United States | $0.328B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.258B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.240B | 0.00 |
| CapsoVision (CV) | United States | $0.185B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.161B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.160B | 0.00 |
| American Well (AMWL) | United States | $0.140B | 0.00 |
| Pulmonx (LUNG) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.118B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.118B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.95 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.099B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.083B | 0.00 |
| 111 (YI) | China | $0.063B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |